Preview

Nephrology (Saint-Petersburg)

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Clinical phenotype in a girl with familial hypomagnesemia with hypercalciuria and nephrocalcinosis

https://doi.org/10.36485/1561-6274-2025-29-4-100-105

EDN: QSENLW

Abstract

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal recessive disorder of the renal tubules caused by mutations in the CLDN 16 or CLDN19 genes encoding the proteins claudin-16 and claudin-19. CLDN 16 or CLDN19 play an important role in the cellular transport of magnesium and calcium in the thick ascending limb of the loop of Henle and are responsible for most of the tubular magnesium reabsorption. FHHNC is characterized by hypomagnesemia, hypercalciuria, medullary nephrocalcinosis, and eye involvement, and progresses to chronic renal failure requiring dialysis and kidney transplantation, mainly in young adults. A clinical case of rapidly progressive renal function decline in a patient with mutations in the CLDN19 gene without ocular involvement is demonstrated.

About the Authors

N. M. Zaikova
Russian National Research Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Prof. Natalia M. Zaikova, MD, PhD, DMedSc

117513, Moscow, Ostovityanova st., 1

Phone: +7 (964) 529-90-49



Dz. D. Magomedova
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Dzhamilya D. Magomedova, MD

117513, Moscow, Ostovityanova st., 1

Phone: +7 (964) 529-90-49



A. R. Hazhieva
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Aminat R. Hazhieva, MD

117513, Moscow, Ostovityanova st., 1

Phone: +7 (964) 062-16-46



References

1. Vall-Palomar M, Madariaga L, Ariceta G. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol 2021;36(10):3045–3055. doi:10.1007/s00467-021-04968-2

2. Vall-Palomar M, Burballa C, Claverie-Martín F, Meseguer A, Ariceta G. Heterogeneity is a common ground in familial hypomagnesemia with hypercalciuria and nephrocalcinosis caused by CLDN19 gene mutations. J Nephrol 2021;34(6):2053–2062. doi:10.1007/s40620-021-01054-6

3. Prot-Bertoye C, Houillier P. Claudins in Renal Physiology and Pathology. Genes (Basel) 2020;11(3):290. Published 2020 Mar 10. doi:10.3390/genes11030290

4. Claverie-Martín F, García-Nieto V, Loris C et al. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 2013;8(1):e53151. doi:10.1371/journal.pone.0053151

5. Wang SB, Xu T, Peng S et al. Disease-associated mutations of claudin-19 disrupt retinal neurogenesis and visual function. Commun Biol 2019;2:113. doi:10.1038/s42003-019-0355-0

6. Lu J, Zhao X, Paiardini A, Lang Y, Bottillo I, Shao L. Familial hypomagnesaemia, Hypercalciuria and Nephrocalcinosis associated with a novel mutation of the highly conserved leucine residue 116 of Claudin 16 in a Chinese patient with a delayed diagnosis: a case report. BMC Nephrol 2018;19(1):181. doi:10.1186/s12882-018-0979-1

7. Félix Claverie-Martín, Víctor García-Nieto, Cesar Loris, Gema Ariceta and alt. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 2013;8(1):53151. doi: 10.1371/journal.pone.0053151

8. Viering DHHM, de Baaij JHF, Walsh SB, Kleta R, Bockenhauer D. Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol 2017;32(7):1123–1135. doi:10.1007/s00467-016-3416-3

9. Prot-Bertoye C, Houillier P. Claudins in Renal Physiology and Pathology. Genes (Basel) 2020;11(3):290. Published 2020 Mar 10. doi:10.3390/genes11030290

10. Houillier P, Lievre L, Hureaux M, Prot-Bertoye C. Mechanisms of paracellular transport of magnesium in intestinal and renal epithelia. Ann N Y Acad Sci 2023;1521(1):14–31. doi:10.1111/nyas.14953

11. Trisvetova E.L. Magnesium in clinical practice. Rational Pharmacotherapy in Cardiology 2012;8(4):545–553. (In Russ.) doi: 10.20996/1819-6446-2012-8-4-545-553

12. Yuan T, Pang Q, Xing X et al. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family. Calcif Tissue Int 2015;96(4):265–273. doi:10.1007/s00223-014-9951-7

13. Plain A, Alexander RT. Claudins and nephrolithiasis. Curr Opin Nephrol Hypertens 2018;27(4):268–276. doi:10.1097/MNH.0000000000000426


Review

For citations:


Zaikova N.M., Magomedova D.D., Hazhieva A.R. Clinical phenotype in a girl with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Nephrology (Saint-Petersburg). 2025;29(4):100-105. (In Russ.) https://doi.org/10.36485/1561-6274-2025-29-4-100-105. EDN: QSENLW

Views: 11

JATS XML

ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)